Skip to content
Research Article Open access CC BY 3.0

The Role of Losartan and Oral Magnesium Sulfate in Cisplatin Induced Nephrotoxicity in Female Rats

Farzaneh Razmjoo, Nepton Soltani, Mehdi Nematbakhsh, Ardeshir Talebi, Fatemeh Eshraghi-Jazi, Mansooreh Ghayyomi

Journal of Pharmaceutical Research International · pp. 1886–1899 · Published 1 Aug 2014

10.9734/BJPR/2014/10164

Abstract

Hypomagnesemia is one of the nephrotoxicity signs. In addition, renin-angiotensin system may be involved in pathophysiology of kidney diseases. Therefore, the present study was designed to investigate the possible role of losartan plus oral magnesium sulfate (MgSO4) to reduce CP-induced nephrotoxicity in female rats. The animals were divided into twelve groups: Group 1-6 received saline, MgSO4 (3g/l), MgSO4(10g/l), losartan, MgSO4 (3g/l) plus losartan, MgSO4 (10g/l) plus losartan, respectively. The animals received MgSO4 via drinking water for 9 days. In addition, losartan (10mg/kg/day; i. p.) was accompanied with MgSO4from day 3. Groups 7-12 followed the same regimen of above groups, but CP (2.5mg/kg/day; i. p.) was added to regimen from day 3. At the end of day 9, all animals were sacrificed and the serum levels of blood urea nitrogen (BUN) and creatinine (Cr) were measured. The kidneys were removed rapidly for histopathological study. The Co-administration of losartan and MgSO4 (3g/l) decreased serum Cr and BUN levels in CP treated animals. Also, that was partially attenuated the kidney tissue damage. It was concluded that combination of losartan and MgSO4 (3g/l) may ameliorate kidney function against CP-induced failure.

Cisplatin nephrotoxicity magnesium sulfate losartan female rat

References (24)

  1. 1 Cisplatin Nephrotoxicity: A Review [DOI]
  2. 2 The Intrarenal Renin-Angiotensin System: From Physiology to the Pathobiology of Hypertension and Kidney Disease [DOI]
  3. 3 Cisplatin and platinum drugs at the molecular level (Review) [DOI]
  4. 4 Agents ameliorating or augmenting the nephrotoxicity of cisplatin and other platinum compounds: A review of some recent research [DOI]
  5. 5 Enhanced Angiotensin II Type 2 Receptor Mechanisms Mediate Decreases in Arterial Pressure Attributable to Chronic Low-Dose Angiotensin II in Female Rats [DOI]
  6. 6 Cisplatin nephrotoxicity [DOI]
  7. 7 Losartan Improves the Impaired Function of Endothelial Progenitor Cells in Hypertension via an Antioxidant Effect [DOI]
  8. 8 The Role of Angiotensin II Receptor 1 (AT1) Blockade in Cisplatin-Induced Nephrotoxicity in Rats: Gender-Related Differences [DOI]
  9. 9 Protective Effects of the Angiotensin II Receptor Blocker Losartan on Cisplatin-Induced Kidney Injury [DOI]
  10. 10 Magnesium Depletion in Patients Receiving Cisplatin-based Chemotherapy [DOI]
  11. 11 Enhanced renal accumulation of cisplatin via renal organic cation transporter deteriorates acute kidney injury in hypomagnesemic rats [DOI]
  12. 12 Effects of Magnesium Sulphate Administration on Aquaporin 3 in Rat Gastrointestinal Tract [DOI]
  13. 13 Vitamin E, Vitamin C, or Losartan Is Not Nephroprotectant against Cisplatin-Induced Nephrotoxicity in Presence of Estrogen in Ovariectomized Rat Model [DOI]
  14. 14 The Role of the Renin-Angiotensin System in Cisplatin Nephrotoxicity [DOI]
  15. 15 The Role of Magnesium Supplementation in Cisplatin-induced Nephrotoxicity in a Rat Model: No Nephroprotectant Effect.
  16. 16 Effect of Oral Administration of Magnesium on Cisplatin-Induced Nephrotoxicity in Normal and Streptozocin-Induced Diabetic Rats [DOI]
  17. 17 Studies on the pathogenesis of cisplatin-induced hypomagnesemia in rats [DOI]
  18. 18 Study of antioxidant properties of metal aspartates [DOI]
  19. 19 Intravenous and Oral Magnesium Supplementations in the Prophylaxis of Cisplatin-Induced Hypomagnesemia [DOI]
  20. 20 A combination of vitamin C and losartan for cisplatin-induced nephrotoxicity in rats.
  21. 21 Magnesium and potassium homeostasis during cisplatin treatment [DOI]
  22. 22 Inhibition of basolateral transport and cellular accumulation of cDDP and N-acetyl-L-cysteine-cDDP by TEA and PAH in the renal proximal tubule [DOI]
  23. 23 Angiotensin 1-7 Receptor and Angiotensin II Receptor 2 Blockades Prevent the Increased Serum and Kidney Nitric Oxide Levels in Response to Angiotensin II Administration: Gender-Related Difference.
  24. 24 Angiotensin II induces p27Kip1 expression in renal tubules in vivo: role of reactive oxygen species [DOI]

Cited by 1

1 citation reported by external sources — individual citing-article records aren't available to list yet.

Related research

Article metrics

Real usage data collected on this platform.

12

Page views

0

PDF downloads

1

Outbound clicks

1

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.